GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (OTCPK:CVALF) » Definitions » Cyclically Adjusted PB Ratio

Covalon Technologies (Covalon Technologies) Cyclically Adjusted PB Ratio : 1.59 (As of May. 22, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Covalon Technologies Cyclically Adjusted PB Ratio?

As of today (2024-05-22), Covalon Technologies's current share price is $0.7962. Covalon Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $0.50. Covalon Technologies's Cyclically Adjusted PB Ratio for today is 1.59.

The historical rank and industry rank for Covalon Technologies's Cyclically Adjusted PB Ratio or its related term are showing as below:

CVALF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.52   Med: 2.67   Max: 11.02
Current: 1.58

During the past years, Covalon Technologies's highest Cyclically Adjusted PB Ratio was 11.02. The lowest was 0.52. And the median was 2.67.

CVALF's Cyclically Adjusted PB Ratio is ranked better than
52.78% of 648 companies
in the Biotechnology industry
Industry Median: 1.745 vs CVALF: 1.58

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Covalon Technologies's adjusted book value per share data for the three months ended in Dec. 2023 was $0.534. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.50 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Covalon Technologies Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Covalon Technologies's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Cyclically Adjusted PB Ratio Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.49 2.12 4.63 3.91 2.17

Covalon Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.69 3.47 2.61 2.17 1.54

Competitive Comparison of Covalon Technologies's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Covalon Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Cyclically Adjusted PB Ratio falls into.



Covalon Technologies Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Covalon Technologies's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.7962/0.5
=1.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Covalon Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Covalon Technologies's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.534/125.0724*125.0724
=0.534

Current CPI (Dec. 2023) = 125.0724.

Covalon Technologies Quarterly Data

Book Value per Share CPI Adj_Book
201403 0.637 98.604 0.808
201406 0.632 99.473 0.795
201409 0.539 99.394 0.678
201412 0.497 98.367 0.632
201503 0.480 99.789 0.602
201506 0.482 100.500 0.600
201509 0.388 100.421 0.483
201512 0.400 99.947 0.501
201603 0.312 101.054 0.386
201606 0.267 102.002 0.327
201609 0.150 101.765 0.184
201612 0.175 101.449 0.216
201703 0.196 102.634 0.239
201706 0.307 103.029 0.373
201709 0.343 103.345 0.415
201712 0.365 103.345 0.442
201803 0.371 105.004 0.442
201806 0.465 105.557 0.551
201809 0.458 105.636 0.542
201812 0.464 105.399 0.551
201903 0.449 106.979 0.525
201906 0.344 107.690 0.400
201909 0.437 107.611 0.508
201912 0.404 107.769 0.469
202003 0.328 107.927 0.380
202006 0.329 108.401 0.380
202009 0.267 108.164 0.309
202012 0.242 108.559 0.279
202103 0.256 110.298 0.290
202106 0.289 111.720 0.324
202109 1.018 112.905 1.128
202112 0.949 113.774 1.043
202203 0.890 117.646 0.946
202206 0.841 120.806 0.871
202209 0.718 120.648 0.744
202212 0.688 120.964 0.711
202303 0.650 122.702 0.663
202306 0.644 124.203 0.649
202309 0.563 125.230 0.562
202312 0.534 125.072 0.534

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Covalon Technologies  (OTCPK:CVALF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Covalon Technologies Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (Covalon Technologies) Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.